Comparison of efficacy of intra-lesional injections of platelet rich plasma therapy versus intralesional triamcinolone acetonide in the treatment of patients with alopecia areata at a tertiary care hospital
Journal of Pakistan Association of Dermatologists · 02.07.2023 · 33 (2) · 637-642
DOI: 10.66344/jpad.v33i2.2494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 02.07.2023. Verfasst von Altaf Hussain und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Alopecia areata (AA) is a prevalent autoimmune disorder characterized by hair loss triggered by inflammation. Platelet-rich plasma (PRP) has recently gained attention as a novel dermatological treatment, with initial findings indicating its potential benefits in promoting hair growth.
Objective
The aim of this study is to evaluate and compare the effectiveness of intralesional injections of platelet-rich plasma therapy with local injections of Triamcinolone acetonide in managing alopecia areata patients.
Methods
It is a randomized controlled trial done at Dermatology Department, Mayo Hospital, Lahore from July, 2022 to January, 2023. Group A received intralesional injections of PRP. Group B received intralesional injections of triamcinolone acetonide (10 mg/ml). The two modalities of treatment were given at 0, 4 and 8 weeks and response was assessed after 1 month of completion of treatment The treatment response was assessed using the Severity of Alopecia Tool (SALT) score, after 12 weeks of therapy. The hair regrowth more than 50% from baseline was considered as efficacious.
Results
Of these 108 study cases, 41 (38.0 %) were male patients while 67 (62.0 %) were female patients. Mean age of our study cases was 31.28 ± 11.55 years. Mean disease duration was 11.31±7.34 months and 70 (64.8 %) had duration of illness more than 6 months. Efficacy was noted in 45 (41.7%), in group A efficacy was noted in 29 (64%) versus 16 (36%) in group B (P=0.011).
Conclusion
The present study revealed that platelet rich plasma injections are effective and safe in patients with alopecia areata compared to Triamcinolone acetonide. Efficacy was higher among patients treated with intra– lesional injections of platelet rich plasma in comparison with Triamcinolone acetonide but not significant as p value (P=0.011).
Zitieren
APA
Hussain, A., Gardezi, S. A. A., Ilyas, S., Sultan, N., & Aman, S. (2023). Comparison of efficacy of intra-lesional injections of platelet rich plasma therapy versus intralesional triamcinolone acetonide in the treatment of patients with alopecia areata at a tertiary care hospital. Journal of Pakistan Association of Dermatologists, 33(2), 637-642. https://doi.org/10.66344/jpad.v33i2.2494
Vancouver
Hussain A, Gardezi SAA, Ilyas S, Sultan N, Aman S. Comparison of efficacy of intra-lesional injections of platelet rich plasma therapy versus intralesional triamcinolone acetonide in the treatment of patients with alopecia areata at a tertiary care hospital. Journal of Pakistan Association of Dermatologists. 2023;33(2):637-642. doi:10.66344/jpad.v33i2.2494
BibTeX
@article{Hussain2023,
author = {Hussain, Altaf and Gardezi, Syed Ahmed Ali and Ilyas, Saima and Sultan, Nadia and Aman, Shahbaz},
title = {Comparison of efficacy of intra-lesional injections of platelet rich plasma therapy versus intralesional triamcinolone acetonide in the treatment of patients with alopecia areata at a tertiary care hospital},
journal = {Journal of Pakistan Association of Dermatologists},
year = {2023},
volume = {33},
number = {2},
pages = {637--642},
doi = {10.66344/jpad.v33i2.2494}
}
EUVIMED